Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Trial Design Choices Watching Dr. Yo's intervie

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155052
(Total Views: 727)
Posted On: 02/11/2021 9:52:40 AM
Posted By: thriftycents
Trial Design Choices

Watching Dr. Yo's interview of Dr. Javitt (RLFTF) this morning.
https://www.youtube.com/watch?v=0tht5jWto4c

Couple of interesting questions/answers that relate to discussions we have had here.

Dr. Yo Asks
Quote:
In one of our earlier discussions and something that really resonated with me was the chest x-ray findings and some of the immunological markers that your team was looking at...I assume you guys are still analyzing the data and if so how much weight does the FDA put on that sort of data? Is that something that supports and confirms? Do they put a lot more weight into that?



Dr. Javitt Answers
Quote:
That's truly supportive data. When we first approached the FDA, the FDA said if you want us to pay attention to this drug, you are going to show us that this drug affects the way patients feel, function and survive. That's what the FDA cares about and that is what the FDA should care about.



Dr. Yo Asks
Quote:
Why did your team choose mortality at 28 days as an endpoint compared to the open label study which was at 60 days?



Dr. Javitt Answers
Quote:
The 28 days is a historical artifact. Artifact is a big word. It's tradition. Basically all of these studies began in the 1990s when we tried to start treating ARDS. And the endpoint that has been used in all the ARDS studies and it has become the standard for anything that's followed is 28 day survival.



I am not suggesting that the FDA shouldn't use marker data or the mortality rate shouldn't be tracked beyond 28 days by default but it's helpful to understand why these decisions were made. Perhaps this is why we have pursued symptom scores (how a patient feels). And perhaps this is why we went with 28 days (I recall Dr. Jay saying that the trial design was in part based on influenza trials).

Anyhow, interesting interview even if you aren't invested in RLFTF.



(8)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us